Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report
Abstract Background Human Cytomegalovirus (HCMV) still represents a crucial concern in solid organ transplant recipients (SOTRs) and the use of antiviral therapy are limited by side effects and the selection of viral mutations conferring antiviral drug resistance. Case presentation Here we reported...
Main Authors: | Stefania Paolucci, Giulia Campanini, Irene Cassaniti, Alessandra Tebaldi, Federica Novazzi, Alice Fratini, Antonella Meini, Federica Girelli, Laura Palumbo, Alessandro Plebani, Fausto Baldanti |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-021-06694-4 |
Similar Items
-
The Role of pUL138 In HCMV Persistence
by: Petrucelli, Alexius
Published: (2011) -
In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation
by: Jochen J Frietsch, et al.
Published: (2019-01-01) -
POSSIBILITIES OF PREVENTION AND TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTIONS INCLUDING NEW DRUGS AND COMPOUNDS WITH POTENTIAL APPLICATION
by: Anna Majewska, et al.
Published: (2019-10-01) -
Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
by: Miho Shibamura, et al.
Published: (2020-08-01) -
Late emergence of A594V and L595W mutations related to ganciclovir resistance in a patient with HCMV retinitis and long-term HIV progression
by: S.N. Slavov, et al.
Published: (2015-01-01)